Effects of resveratrol on cell growth and prolactin synthesis in GH3 cells

Experimental and Therapeutic Medicine

Volumn 7, Issue 4, 2014, Pages 923-928

  Chao, Wang ^a   Xuexin, Zhang ^a   Jun, Su ^a   Ming, Chu ^a   Hua, Jin ^a   Li, Guofu ^a   Tan, Chunlei ^a   Xu, Wanhai ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Estrogen; Prolactinoma; Resveratrol

Indexed keywords

CASPASE 3; CASPASE 8; ESTRADIOL; FLUORESCEIN ISOTHIOCYANATE; PROLACTIN; RESVERATROL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN GH3; CHEMOPROPHYLAXIS; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROLACTINOMA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84896716151     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1544     Document Type: Article

References (21)

1. Heaney AP, Fernando M and Melmed S: Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109: 277-283, 2002.
2. Freeman ME, Kanyicska B, Lerant A and Nagy G: Prolactin: structure, function, and regulation of secretion. Physiol Rev 80: 1523-1631, 2000.
3. Yin P, Kawashima K and Arita J: Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats. Neuroendocrinology 75: 392-401, 2002.
4. Caporali S, Imai M, Altucci L, et al: Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Mol Biol Cell 14: 5051-5059, 2003.
5. Friend KE, Ang LW and Shupnik MA: Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 92: 4367-4371, 1995.
6. Jaffrain-Rea ML, Petrangeli E, Ortolani F, et al: Cellular receptors for sex steroids in human pituitary adenomas. J Endocrinol 151: 175-184, 1996.
7. Nakao H, Koga M, Arao M, et al: Enzyme-immunoassay for estrogen receptors in human pituitary adenomas. Acta Endocrinol (Copenh) 120: 233-238, 1989.
8. Lee SY, Ahn BT, Baik SH and Lee BL: Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis. Neurosurgery 43: 116-123, 1998.
9. Bowers JL, Tyulmenkov VV, Jernigan SC and Klinge CM: Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141: 3657-3667, 2000.
10. Jang M, Cai L, Udeani GO, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
11. Boockfor FR, Hoeffler JP and Frawley LS: Cultures of GH3 cells are functionally heterogeneous: thyrotropin-releasing hormone, estradiol and cortisol cause reciprocal shifts in the proportions of growth hormone and prolactin secretors. Endocrinology 117: 418-420, 1985.
12. Iwasaka T, Umemura S, Kakimoto K, Koizumi H and Osamura YR: Expression of prolactin mRNA in rat mammary gland during pregnancy and lactation. J Histochem Cytochem 48: 389-396, 2000.
13. Shaw-Bruha CM, Pennington KL and Shull JD: Identification in the rat prolactin gene of sequences homologous to the distal promoter of the human prolactin gene. Biochim Biophys Acta 1442: 304-313, 1998.
14. Wang C, Hu ZQ, Chu M, et al: Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors. Clin Neurol Neurosurg 114: 241-248, 2012.
15. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002.
16. Chu M, Hu ZQ, Wei LL, Zhang SZ, Hu EX and Dong Q: Inhibitory effect of resveratrol in pituitary GH3 cells. Chin J Neurosurg 21: 105-109, 2005 (In Chinese).
17. Yamashita H, Okadome T, Franzén P, ten Dijke P, Heldin CH and Miyazono K: A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta. J Biol Chem 270: 770-774, 1995.
18. Kakeya T, Takeuchi S and Takahashi S: Epidermal growth factor, insulin, and estrogen stimulate development of prolactin-secreting cells in cultures of GH3 cells. Cell Tissue Res 299: 237-243, 2000.
19. Kansra S, Yamagata S, Sneade L, Foster L and Ben-Jonathan N: Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 239: 27-36, 2005.
20. Schreihofer DA, Stoler MH and Shupnik MA. Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness. Endocrinology 141: 2174-2184, 2000.
21. Mitchner NA, Garlick C, Steinmetz RW and Ben-Jonathan N: Differential regulation and action of estrogen receptors alpha and beta in GH3 cells. Endocrinology 140: 2651-2658, 1999.